PAVmed (PAVM) Shareholder's Equity Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 993.79% |
| Jun 30, 2025 | 251.05% |
| Mar 31, 2025 | 289.22% |
| Dec 31, 2024 | 89.61% |
| Jun 30, 2024 | -2,146.02% |
| Mar 31, 2024 | -290.44% |
| Dec 31, 2023 | -319.66% |
| Sep 30, 2023 | -155.43% |
| Jun 30, 2023 | -102.00% |
| Mar 31, 2023 | -83.31% |
| Dec 31, 2022 | -86.23% |
| Sep 30, 2022 | -18.95% |
| Jun 30, 2022 | -1.51% |
| Mar 31, 2022 | 34.75% |
| Dec 31, 2021 | 16,890.27% |
| Sep 30, 2021 | 338.70% |
| Jun 30, 2021 | 428.31% |
| Mar 31, 2021 | 396.01% |
| Dec 31, 2020 | 89.80% |
| Sep 30, 2020 | -513.25% |
| Jun 30, 2020 | -581.48% |
| Mar 31, 2020 | -186.33% |
| Dec 31, 2019 | -87.32% |
| Sep 30, 2019 | -167.54% |
| Jun 30, 2019 | -128.81% |
| Mar 31, 2019 | -2,387.00% |
| Dec 31, 2018 | 13.07% |
| Sep 30, 2018 | 160.27% |
| Jun 30, 2018 | 229.15% |
| Mar 31, 2018 | 105.74% |
| Dec 31, 2017 | -792.71% |
| Sep 30, 2017 | -617.02% |
| Jun 30, 2017 | -283.67% |
| Dec 31, 2016 | -150.33% |